Your browser doesn't support javascript.
loading
Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.
Shih, Han-Po; Ding, Jing-Ya; Sotolongo Bellón, Junel; Lo, Yu-Fang; Chung, Pei-Han; Ting, He-Ting; Peng, Jhan-Jie; Wu, Tsai-Yi; Lin, Chia-Hao; Lo, Chia-Chi; Lin, You-Ning; Yeh, Chun-Fu; Chen, Jiun-Bo; Wu, Ting-Shu; Liu, Yuag-Meng; Kuo, Chen-Yen; Wang, Shang-Yu; Tu, Kun-Hua; Ng, Chau Yee; Lei, Wei-Te; Tsai, Yu-Huan; Chen, Jou-Han; Chuang, Ya-Ting; Huang, Jing-Yi; Rey, Félix A; Chen, Hung-Kai; Chang, Tse-Wen; Piehler, Jacob; Chi, Chih-Yu; Ku, Cheng-Lung.
Afiliação
  • Shih HP; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Ding JY; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Sotolongo Bellón J; Division of Biophysics, Department of Biology, University of Osnabruck, Osnabruck, Germany.
  • Lo YF; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Chung PH; Elixiron Immunotherapeutics, Taipei, Taiwan.
  • Ting HT; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Peng JJ; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Wu TY; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Lin CH; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Lo CC; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Lin YN; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Yeh CF; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Chen JB; Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
  • Wu TS; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Liu YM; Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
  • Kuo CY; Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Wang SY; Division of Infectious Diseases, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan.
  • Tu KH; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Ng CY; Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Lei WT; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Tsai YH; Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chen JH; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Chuang YT; Chang Gung University College of Medicine, Taoyuan, Taiwan.
  • Huang JY; Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Rey FA; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Chen HK; Department of Dermatology, Chang Gung Memorial Hospital, Taipei, Taiwan.
  • Chang TW; Laboratory of Human Immunology and Infectious Disease, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan.
  • Piehler J; Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.
  • Chi CY; Laboratory of Host-Microbe Interactions and Cell Dynamics, Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Ku CL; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
J Exp Med ; 219(9)2022 09 05.
Article em En | MEDLINE | ID: mdl-35833912
ABSTRACT
Anti-interferon (IFN)-γ autoantibodies (AIGAs) are a pathogenic factor in late-onset immunodeficiency with disseminated mycobacterial and other opportunistic infections. AIGAs block IFN-γ function, but their effects on IFN-γ signaling are unknown. Using a single-cell capture method, we isolated 19 IFN-γ-reactive monoclonal antibodies (mAbs) from patients with AIGAs. All displayed high-affinity (KD < 10-9 M) binding to IFN-γ, but only eight neutralized IFN-γ-STAT1 signaling and HLA-DR expression. Signal blockade and binding affinity were correlated and attributed to somatic hypermutations. Cross-competition assays identified three nonoverlapping binding sites (I-III) for AIGAs on IFN-γ. We found that site I mAb neutralized IFN-γ by blocking its binding to IFN-γR1. Site II and III mAbs bound the receptor-bound IFN-γ on the cell surface, abolishing IFN-γR1-IFN-γR2 heterodimerization and preventing downstream signaling. Site III mAbs mediated antibody-dependent cellular cytotoxicity, probably through antibody-IFN-γ complexes on cells. Pathogenic AIGAs underlie mycobacterial infections by the dual blockade of IFN-γ signaling and by eliminating IFN-γ-responsive cells.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interferon / Infecções por Mycobacterium Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Interferon / Infecções por Mycobacterium Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article